Applications of artificial intelligence and machine learning in heart failure

Author:

Averbuch Tauben1ORCID,Sullivan Kristen1,Sauer Andrew2,Mamas Mamas A3,Voors Adriaan A4,Gale Chris P5ORCID,Metra Marco6,Ravindra Neal7,Van Spall Harriette G C189ORCID

Affiliation:

1. Department of Medicine, McMaster University , Hamilton, Ontario , Canada

2. Department of Cardiology, University of Kansas Health System , Kansas City, KS , USA

3. Keele Cardiovascular research group, Keele University , Stoke on Trent, Staffordshire

4. University of Groningen , Groningen , The Netherlands

5. Department of Cardiology, University of Leeds , Leeds, West Yorkshire

6. Azienda Socio Sanitaria Territoriale Spedali Civili and University of Brescia , Brescia , Italy

7. Department of Computer Science, Yale University , New Haven, CT , USA

8. Population Health Research Institute , Hamilton, Ontario , Canada

9. Department of Health Research Methods, Evidence, and Impact, McMaster University , Hamilton, Ontario , Canada

Abstract

Abstract Machine learning (ML) is a sub-field of artificial intelligence that uses computer algorithms to extract patterns from raw data, acquire knowledge without human input, and apply this knowledge for various tasks. Traditional statistical methods that classify or regress data have limited capacity to handle large datasets that have a low signal-to-noise ratio. In contrast to traditional models, ML relies on fewer assumptions, can handle larger and more complex datasets, and does not require predictors or interactions to be pre-specified, allowing for novel relationships to be detected. In this review, we discuss the rationale for the use and applications of ML in heart failure, including disease classification, early diagnosis, early detection of decompensation, risk stratification, optimal titration of medical therapy, effective patient selection for devices, and clinical trial recruitment. We discuss how ML can be used to expedite implementation and close healthcare gaps in learning healthcare systems. We review the limitations of ML, including opaque logic and unreliable model performance in the setting of data errors or data shift. Whilst ML has great potential to improve clinical care and research in HF, the applications must be externally validated in prospective studies for broad uptake to occur.

Funder

Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada

Publisher

Oxford University Press (OUP)

Subject

Energy Engineering and Power Technology,Fuel Technology

Reference61 articles.

1. Derivation and validation of a two-variable index to predict 30-day outcomes following heart failure hospitalization;Averbuch;ESC Heart Fail,2021

2. The LENT index predicts 30 day outcomes following hospitalization for heart failure;Van Spall;ESC Heart Fail,2021

3. The rise of big clinical databases;Cook;Br J Surg,2015

4. Exploiting big data for critical care research;Docherty;Curr Opin Crit Care,2015

5. Introduction to machine learning, neural networks, and deep learning;Choi;Transl Vis Sci Technol,2020

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3